Literature DB >> 7295491

Long-term low dose haloperidol treatment in rheumatoid patients: effects on serum sulphydryl levels, technetium index, ESR, and clinical response.

M G Grimaldi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7295491      PMCID： PMC1401902          DOI： 10.1111/j.1365-2125.1981.tb01268.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  13 in total

1.  Tissue sulfhydryl groups.

Authors:  G L ELLMAN
Journal:  Arch Biochem Biophys       Date:  1959-05       Impact factor: 4.013

2.  Objective measurement of rheumatoid arthritis using technetium index.

Authors:  E C Huskisson; J Scott; H W Balme
Journal:  Ann Rheum Dis       Date:  1976-02       Impact factor: 19.103

3.  Characterization of receptors mediating 5-hydroxytryptamine- and catecholamine-induced platelet aggregation, assessed by the actions of alpha- and beta-blockers, butyrophenones, 5-HT antagonists and chlorpromazine.

Authors:  D J Boullin; P A Glenton
Journal:  Br J Pharmacol       Date:  1978-04       Impact factor: 8.739

4.  A homologous radioimmunoassay for human prolactin.

Authors:  Y N Sinha; F W Selby; U J Lewis; W P VanderLaan
Journal:  J Clin Endocrinol Metab       Date:  1973-03       Impact factor: 5.958

5.  Some observations on the blood serotonin levels in rheumatoid arthritis with a study of platelet serotonin absorption.

Authors:  N Crawford
Journal:  Clin Chim Acta       Date:  1969-01       Impact factor: 3.786

6.  On the effects of antirheumatic drugs on protein sulphydryl reactivity in human serum.

Authors:  M E Pickup; J S Dixon; H A Bird
Journal:  J Pharm Pharmacol       Date:  1980-04       Impact factor: 3.765

7.  Effects of antirheumatic drugs on protein sulphydryl reactivity of human serum.

Authors:  N C Hall; A H Gillan
Journal:  J Pharm Pharmacol       Date:  1979-10       Impact factor: 3.765

8.  Serum sulfhydryl levels in rheumatoid patients treated with haloperidol.

Authors:  M G Grimaldi
Journal:  Scand J Rheumatol       Date:  1980       Impact factor: 3.641

9.  The binding of haloperidol to human blood platelets and interactions with 5-hydroxytryptamine and dopamine.

Authors:  D J Boullin; D Molyneux; B Roach
Journal:  Br J Pharmacol       Date:  1978-07       Impact factor: 8.739

10.  SOluble and insoluble immune complex-platelet interactions in rheumatoid inflammation.

Authors:  R P Yeatts; R Turner; R Collins; J Kaufmann; H Mashburn
Journal:  Ann Rheum Dis       Date:  1978-10       Impact factor: 19.103
View more
  8 in total

Review 1.  Slow drugs: slow progress? Use of slow acting antirheumatic drugs (SAARDs) in rheumatoid arthritis.

Authors:  H A Capell; M Brzeski
Journal:  Ann Rheum Dis       Date:  1992-03       Impact factor: 19.103

Review 2.  Disease modifying drugs for rheumatoid arthritis: yesterday's treatment today or today's treatment tomorrow?

Authors:  T Pullar
Journal:  Br J Clin Pharmacol       Date:  1990-10       Impact factor: 4.335

3.  Long-term low dose ticlopidine treatment in rheumatoid arthritis: effects on serum sulphydryl levels, technetium index, erythrocyte sedimentation rate, and clinical disease activity.

Authors:  M G Grimaldi
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

4.  Prolactin promotes cartilage survival and attenuates inflammation in inflammatory arthritis.

Authors:  Norma Adán; Jessica Guzmán-Morales; Maria G Ledesma-Colunga; Sonia I Perales-Canales; Andrés Quintanar-Stéphano; Fernando López-Barrera; Isabel Méndez; Bibiana Moreno-Carranza; Jakob Triebel; Nadine Binart; Gonzalo Martínez de la Escalera; Stéphanie Thebault; Carmen Clapp
Journal:  J Clin Invest       Date:  2013-08-01       Impact factor: 14.808

Review 5.  Dual Roles of Prolactin and Vasoinhibin in Inflammatory Arthritis.

Authors:  Carmen Clapp; Georgina Ortiz; Jose F García-Rodrigo; María G Ledesma-Colunga; Oscar F Martínez-Díaz; Norma Adán; Gonzalo Martínez de la Escalera
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-02       Impact factor: 6.055

Review 6.  The role of the prolactin/vasoinhibin axis in rheumatoid arthritis: an integrative overview.

Authors:  Carmen Clapp; Norma Adán; María G Ledesma-Colunga; Mariana Solís-Gutiérrez; Jakob Triebel; Gonzalo Martínez de la Escalera
Journal:  Cell Mol Life Sci       Date:  2016-03-29       Impact factor: 9.261

7.  Prolactin blocks the expression of receptor activator of nuclear factor κB ligand and reduces osteoclastogenesis and bone loss in murine inflammatory arthritis.

Authors:  Maria G Ledesma-Colunga; Norma Adán; Georgina Ortiz; Mariana Solís-Gutiérrez; Fernando López-Barrera; Gonzalo Martínez de la Escalera; Carmen Clapp
Journal:  Arthritis Res Ther       Date:  2017-05-15       Impact factor: 5.156

8.  Repurposing haloperidol for the treatment of rheumatoid arthritis: an integrative approach using data mining techniques.

Authors:  Chihiro Nakagawa; Satoshi Yokoyama; Kouichi Hosomi; Mitsutaka Takada
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-09-23       Impact factor: 5.346
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.